Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines

作者: Jeffrey Kreisberg , Shazli Malik , Shujie Zhao , James W Freeman , Daniel DeArmond

DOI: 10.1038/SJ.ONC.1206966

关键词:

摘要: Pancreatic ductal adenocarcinoma (PDAC) cell lines, MIA PaCa-2, and UK Pan-1, were used to investigate the role of ErbB2 in PDAC oncogenesis. Both these lines exhibit exogenous growth factor-independent proliferation that was attributed production autocrine factors and/or overexpression factor receptors. The phenotype displayed by dependent on kinase activity since treatment cells with tyrphostin AG879 prevented serum-free media (SFM) induction proliferation. We determined contributed aberrant cycle regulation through cyclin D1 levels suppression p21Cip1 p27Kip1. Inhibition led arrest marked an increased association p27Kip1 cdk2 reduced phosphorylated pRb. further observed constitutive STAT3 activation increase upon stimulating quiescent SFM. Inhibitors blocked activation, whereas inhibition EGFR a slight reduction activation. coimmunoprecipitated ErbB2. SFM stimulation caused STAT3, which kinase. Expression dominant negative SFM-stimulated PaCa-2 cells, suggesting is required for cells. Consistent this observation we found most tumor specimens (10 11) showed readily detected tumors (nine 11). believe findings indicate novel mechanism oncogenesis may suggest future therapeutic strategies PDAC.

参考文章(50)
Eric Caldenhoven, Thamar B. van Dijk, Roberto Solari, John Armstrong, Jan A. M. Raaijmakers, Jan-Willem J. Lammers, Leo Koenderman, Rolf P. de Groot, STAT3β, a Splice Variant of Transcription Factor STAT3, Is a Dominant Negative Regulator of Transcription Journal of Biological Chemistry. ,vol. 271, pp. 13221- 13227 ,(1996) , 10.1074/JBC.271.22.13221
Leah N. Klapper, Mark H. Kirschbaum, Michael Seta, Yosef Yarden, Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors Advances in Cancer Research. ,vol. 77, pp. 25- 79 ,(1999) , 10.1016/S0065-230X(08)60784-8
Douglas W. Leaman, Stewart Leung, Xiaoxia Li, George R. Stark, Regulation of STAT-dependent pathways by growth factors and cytokines. The FASEB Journal. ,vol. 10, pp. 1578- 1588 ,(1996) , 10.1096/FASEBJ.10.14.9002549
Lieven M. K. Vandersypen, Isaac L. Chuang, Xinlan Zhou, Debbie W. Leung, Seth Lloyd, Experimental realization of a quantum algorithm Nature. ,vol. 393, pp. 143- 146 ,(1998) , 10.1038/30181
Andrei L Gartel, Feridoon Najmabadi, Eugene Goufman, Angela L Tyner, A role for E2F1 in Ras activation of p21(WAF1/CIP1) transcription Oncogene. ,vol. 19, pp. 961- 964 ,(2000) , 10.1038/SJ.ONC.1203411
Daniel Harari, Yosef Yarden, Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene. ,vol. 19, pp. 6102- 6114 ,(2000) , 10.1038/SJ.ONC.1203973
J E Somerville, L A Clarke, J D Biggart, c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma. Journal of Clinical Pathology. ,vol. 45, pp. 16- 20 ,(1992) , 10.1136/JCP.45.1.16
Chris Albanese, Janet Johnson, Genichi Watanabe, Nathan Eklund, Dzuy Vu, Andrew Arnold, Richard G. Pestell, Transforming p21ras Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions Journal of Biological Chemistry. ,vol. 270, pp. 23589- 23597 ,(1995) , 10.1074/JBC.270.40.23589
Andrea D Basso, David B Solit, Pamela N Munster, Neal Rosen, Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2. Oncogene. ,vol. 21, pp. 1159- 1166 ,(2002) , 10.1038/SJ.ONC.1205184
William M Burke, Xiaohong Jin, Huey-Jen Lin, Melinda Huang, Rebecca Liu, R Kevin Reynolds, Jiayuh Lin, Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells Oncogene. ,vol. 20, pp. 7925- 7934 ,(2001) , 10.1038/SJ.ONC.1204990